Prenatal therapy in congenital adrenal hyperplasia. Attempted prevention of abnormal external genital masculinization by pharmacologic suppression of the fetal adrenal gland in utero.
D000311:Adrenal Glands / Q000196:embryology*; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy* / Q000235:genetics; D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis; D003165:Complement System Proteins / Q000235:genetics; D003864:Depression, Chemical; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006680:HLA Antigens / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D010375:Pedigree; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011247:Pregnancy; D012306:Risk; D013250:Steroid Hydroxylases / Q000172:deficiency*
D006680:HLA Antigens; D003907:Dexamethasone; D003165:Complement System Proteins; D013250:Steroid Hydroxylases